The Coordinating and
Information Resource Center for International Travel by Patients Receiving
Methadone and other Substitution Treatments for Opiate Addiction
Methadone is used in the treatment of opiate addiction in at least 65 countries, including pilot programs:
Albania, Armenia, Australia, Austria, Azerbaijan, Belgium, Bosnia and Herzegovina, Bulgaria, Canada, China (including Hong Kong), Colombia, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Georgia, Germany, Greece, Hungary, Iceland, Indonesia, Iran, Ireland, Israel, Italy, Kazakhstan, Kenia, Kyrgyzstan, Latvia, Liechtenstein, Lithuania, Luxembourg, Macedonia, Malaysia, Maldives, Malta, Mauritius, Mexico, Moldova, Montenegro, Morocco, Myanmar, Nepal, the Netherlands, New Zealand, Norway, Poland, Portugal, Romania, Serbia, Slovak Republic, Slovenia, South Africa, Spain, Sweden, Switzerland, Taiwan, Thailand, Ukraine, United Kingdom (plus overseas territories/dependencies), United States of America, Vietnam.
Buprenorphine treatment (including pilot programs) is currently available in at least 48 countries:
Australia, Austria, Belgium, Canada, China (Hong Kong), Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, India, Indonesia, Iran, Ireland, Israel, Italy, Latvia, Lebanon, Liechtenstein, Lithuania, Luxembourg, Malaysia, Malta, Nepal, the Netherlands, New Zealand, Norway, Poland, Portugal, Romania, Senegal, Slovak Republic, Slovenia, South Africa, Spain, Sweden, Switzerland, Taiwan, Thailand, Ukraine, United Kingdom, United States of America
We estimate a total of at least 1,300,000 patients currently participating in opioid substitution treatments [including patients receiving slow-release morphine (e.g. Austria and France), dihydrocodeine or codeine (e.g. Germany) or diamorphine (e.g. Germany, Switzerland, the Netherlands).
Clearly it must be said that in most countries opioid substitution treatment is not available nation-wide. Also, some countries provide opioid substitution treatments to a limited number of patients only. Moreover, regulations and treatment philosophies as well as (approved) patient numbers vary enormously.
Any corrections, additions or deletions that readers feel should be made to the listing of countries given above and/or the travel guide are greatly appreciated.